Assistant Professor of @CUSurgOnc, Nicole Christian, MD, wrote a new article on physicians' well-being, especially ones who are looking to become parents.
Read her article here: https://t.co/0JWj9C0IYh
Last day of my last surgical rotation at @dgsomUCLA@UCLASurgery 🙌🏽
It’s been a privilege to learn from supportive mentors & colleagues, and to walk alongside patients in their most vulnerable.
Next up: completing #Match2023 apps then off to @UMichSurgery!
PSR is saddened to learn that Dr. H Jack Geiger, one of PSR’s founders, has passed away at 95. Dr. Geiger helped found PSR in 1961, but that was just one of many accomplishments that contribute to his legacy as a champion for social justice. https://t.co/iev1csIqdl
The current lack of sex-specific treatment guidelines overlooks the innate physiological and biochemical differences contributing to cardiovascular disease progression and outcomes. So many missing pieces. @jocalynclark@NIH_ORWH#cardiotwitter#womenshealth#Cardiovascular
Dr. Clark expresses concern that though there has been great progress in sex and gender research reporting, there are still many missing pieces that lead to failure of accountability. #SCORE2020
We will now break for lunch. Please register at https://t.co/Zt72SCqocv to visit the poster hall, to view the BIRCWH scholar presentations, and to participate in the 5 p.m. ET networking session. #2020BIRCWH
So grateful to have had this incredible, inspiring woman @RWalensky at @UCLA_ID grand rounds today talking cost effectiveness in HIV treatment.
Thank you @doc_in_a_box!
Government service was never part of my plans. But every doctor knows that when a patient is coding, your plans don’t matter. You run to the code.
And when a nation is coding—if you are called to serve, you serve.
The most important paper on #COVID19 and #troponin so far 👏🏻. Big congrats to the authors! @ErinMichos et al
Myocardial Injury in Severe COVID-19 Compared to Non-COVID Acute Respiratory Distress Syndrome | Circulation https://t.co/vKZJO5rCot
ICYMI: Is Sacubitril/Valsartan safe and effective in reducing risk of #CVD death in #HFrEF patients? A new #JACCHF state-of-the-art review looks at neprilysin inhibition five years after PARADIGM-HF. Read more: https://t.co/w3JtP9oUNq @mvaduganathan
Finished 9 weeks of block 6 (aka bugs and drugs). So grateful to have had such outstanding block chairs @tara_vijayan @omaigarner here at @UCLAHealth to learn from and who constantly keep us engaged and humbled by the impact these tiny bugs can have on our lives. ID, I’m in.